PhRMA Exec VP Conafay resigns; committee of three company reps will guide lobbying effort in interim.
Executive Summary
PhRMA CAPITOL HILL EFFORT WILL BE OVERSEEN BY THREE COMPANY EXECS from the government affairs offices of member companies following the Dec. 13 resignation by association Exec VP Stephen Conafay. The heads of the D.C. offices of Warner-Lambert (Vincent LoVoi) and Bristol-Myers Squibb (Richard Thompson) and the director of public policy at Lilly in Indianapolis (Anne Nobles) have been assigned to maintain the association's lobbying efforts. The three representatives were chosen because they are the top federal government relations staff for the current chairman of the association (Warner-Lambert's Lodewijk de Vink), the upcoming chairman (BMS Chairman Charles Heimbold), and the treasurer and chairman for 1997-1998 (Lilly Exec VP Sidney Taurel).